1. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Issue 8 (August 2018) Authors: Bisogno, Gianni; Jenney, Meriel; Bergeron, Christophe; Gallego Melcón, Soledad; Ferrari, Andrea; Oberlin, Odile; Carli, Modesto; Stevens, Michael; Kelsey, Anna; De Paoli, Angela; Gaze, Mark N; Martelli, Helene; Devalck, Christine; Merks, Johannes H; Ben-Arush, Myriam; Glosli, Heidi; Chisholm, Jul... Journal: Lancet oncology Issue: Volume 19:Issue 8(2018) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study. (August 2022) Authors: Ferrari, Andrea; Chisholm, Julia C; Jenney, Meriel; Minard-Colin, Veronique; Orbach, Daniel; Casanova, Michela; Guillen, Gabriela; Glosli, Heidi; van Rijn, Rick R; Schoot, Reineke A; Cameron, Alison L; Rogers, Timothy; Alaggio, Rita; Ben-Arush, Myriam; Mandeville, Henry C; Devalck, Christine; Def... Journal: Lancet Issue: Volume 6:Number 8(2022) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group. (September 2022) Authors: Ben-Arush, Myriam; Minard-Colin, Veronique; Scarzello, Giovanni; Fajardo, Raquel D.; Terwisscha Van Scheltinga, Sheila; Bernier, Valérie; Jenney, Meriel; Gallego, Soledad; Zanetti, Ilaria; Cesen, Maja; Merks, Johannes H.M.; Bisogno, Gianni Journal: European journal of cancer Issue: Volume 172(2022) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Issue 11 (November 2019) Authors: Bisogno, Gianni; De Salvo, Gian Luca; Bergeron, Christophe; Gallego Melcón, Soledad; Merks, Johannes H; Kelsey, Anna; Martelli, Helene; Minard-Colin, Veronique; Orbach, Daniel; Glosli, Heidi; Chisholm, Julia; Casanova, Michela; Zanetti, Ilaria; Devalck, Christine; Ben-Arush, Myriam; Mudry, Peter;... Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: 1566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗